Burckhardt Compression (BCHN) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
4 Nov, 2025Executive summary
Sales increased by 2.8% year-over-year to CHF 516.2 mn, supported by a large order backlog and operational strength despite global uncertainty and currency fluctuations.
Net income remained stable at CHF 48.7 mn, down 0.9% year-over-year, with EBIT margin at 12.7%, slightly below the previous year.
Order intake declined 34.9% year-over-year to CHF 400.7 mn, mainly due to deferred projects in the Systems Division following US tariff announcements and market uncertainties.
Resilience supported by diverse end-market presence, operational excellence, and targeted cost reduction measures.
Acquisition of Advanced Compressor Technology in the US enhances local manufacturing, service, and spare parts capabilities.
Financial highlights
Sales: CHF 516.2 mn (+2.8% y-o-y); gross profit: CHF 146.2 mn (+2.0% y-o-y); gross margin at 28.3%.
Operating income (EBIT): CHF 65.5 mn (-2.3% y-o-y); EBIT margin: 12.7% (down 0.7pp).
SG&A expenses stable at 12.3% of sales; R&D expenses increased to 2.9% of sales, focusing on marine, hydrogen, and digital solutions.
Positive net financial position of CHF 6.3 mn, with borrowings reduced and cash position at CHF 159.7 mn at period end.
Shareholders’ equity increased to CHF 303.8 mn, with an equity ratio of 26.1%.
Outlook and guidance
FY 2025 sales expected at ~CHF 1.1 bn, with EBIT margin similar to FY 2024 and stronger profitability anticipated in H2.
Mid-term plan remains on track, underpinned by global megatrends in energy and industrial demand.
Order backlog provides visibility and confidence in meeting guidance.
Latest events from Burckhardt Compression
- Record financial results and raised 2027 sales guidance to CHF 1.2 billion.BCHN
H2 202431 Jan 2026 - Record sales and strong margins with a stable outlook, driven by global megatrends and marine demand.BCHN
H2 202513 Nov 2025 - Strong growth, margin expansion, and robust outlook support confirmed guidance.BCHN
H1 202513 Jun 2025